Garet, Bassel Traboulsi; García, Adrià Jorba; Font, Octavi Camps; Alves, Fábio Abreu 
; Figueiredo, Rui; Castellón, Eduard Valmaseda
Source: Clinical Oral Investigations. Unidade: FO
Subjects: OSTEONECROSE, MANDÍBULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARET, Bassel Traboulsi et al. Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy. Clinical Oral Investigations, v. 26, n. Ja 2022, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00784-022-04383-3. Acesso em: 04 maio 2024.APA
Garet, B. T., García, A. J., Font, O. C., Alves, F. A., Figueiredo, R., & Castellón, E. V. (2022). Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy. Clinical Oral Investigations, 26( Ja 2022). doi:10.1007/s00784-022-04383-3NLM
Garet BT, García AJ, Font OC, Alves FA, Figueiredo R, Castellón EV. Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy [Internet]. Clinical Oral Investigations. 2022 ; 26( Ja 2022):[citado 2024 maio 04 ] Available from: https://doi.org/10.1007/s00784-022-04383-3Vancouver
Garet BT, García AJ, Font OC, Alves FA, Figueiredo R, Castellón EV. Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy [Internet]. Clinical Oral Investigations. 2022 ; 26( Ja 2022):[citado 2024 maio 04 ] Available from: https://doi.org/10.1007/s00784-022-04383-3
